InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Bayer hits back over Indian complusory licence ruling

Emma Barraclough, London


German pharmaceutical company Bayer says it will appeal yesterday’s decision by India’s IP Appellate Board to uphold a compulsory licence granted over its cancer drug Nexavar

The Board backed an order granted last year by the then head of India’s IP Office, PH Kurian, that gave local generic drug company Natco a licence to produce a version of sorafenib, which is used to treat kidney and...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements